logo
Select company
Select metric
16.91%Cash to Assets Ratio
VS
Market
70
Sector
39
Industry
49
History
16
$ 3.18Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information

Ticker

VVOS

Company Name

VIVOS THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VIVOS THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VVOS - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 26.03M$ 4.4M16.91%
3/31/2025$ 11.28M$ 2.34M20.76%
12/31/2024$ 15.28M$ 6.26M40.96%
9/30/2024$ 15.35M$ 6.31M41.12%
6/30/2024$ 15.84M$ 6.9M43.57%
3/31/2024$ 11.8M$ 2.61M22.12%
12/31/2023$ 10.73M$ 1.64M15.31%
9/30/2023$ 10.32M$ 988K9.58%
6/30/2023$ 13.75M$ 3.94M28.67%
3/31/2023$ 17.1M$ 7.05M41.2%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 9.95%.
  • Over the past 5 years, VIVOS THERAPEUTICS INC's average Cash to Assets has been 39.5%.
  • The median Cash to Assets for VIVOS THERAPEUTICS INC during this period was 38.74%
  • VIVOS THERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 74.9%.
  • The lowest Cash to Assets recorded by VIVOS THERAPEUTICS INC in the same timeframe 9.58%

VIVOS THERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP 74.31%XLO : XILIO THERAPEUTICS INC 92.18%NEPH : NEPHROS INC 41.44%ALUR : ALLURION TECHNOLOGIES INC 45.16%POCI : PRECISION OPTICS CORPORATION INC 8.96%COCH : ENVOY MEDICAL INC 53.4%NXGL : NEXGEL INC 7.47%BCAB : BIOATLA INC 67.11%XAIR : BEYOND AIR INC 18.28%CRIS : CURIS INC 34.68%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for VIVOS THERAPEUTICS INC is calculated as follows: CashnEq [ $ 751.59K ] / Assets [ $ 7.55M ]
(=) Cash to Assets [ 9.95% ]

VVOS - Cash to Assets Ratio, Last 5 years

9.58%

Minimum

Sep 30, 2023

74.9%

Maximum

Jun 30, 2021

39.5%

Average

38.74%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%